Symptom Improvement with BDP/FF/G Fixed Triple Inhalation Powder in Moderate to Severe COPD Patients Uncontrolled with Dual Therapies: A Non-Interventional, Open-Label, Single-Arm, Prospective Study (RESPONSE Slovenia)

People living with COPD are frequently inadequately treated due to underdiagnosis or misdiagnosis. The aim of this study was to evaluate the real-world performance of the beclomethasone dipropionate/formoterol fumarate/glycopyrronium (BDP/FF/G) fixed triple combination formulated in a dry powder inh...

Полное описание

Библиографические подробности

Главные авторы:	Matevž Harlander, Tjaša Šubic, Renato Eržen, Arjana Maček Cafuta, Anton Lopert, Alojz Horvat, Dušan Božič, Albert Klobučar, Zoran Krstić, Nataša Todorović, Nina Sobotkiewicz, Simona Kirbiš, Ana Novaković, Nikša Šegota, Branislav Červenjak, Jasmina Panjan Avramovič, Kata Paun, Lucija Gabršček Parežnik
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Taylor & Francis Group 2026-06-01
Серии:	COPD
Предметы:	Beclomethasone dipropionate/formoterol fumarate/glycopyrronium COPD COPD assessment tool (CAT) DPI mMRC NEXThaler®
Online-ссылка:	https://www.tandfonline.com/doi/10.1080/15412555.2026.2681198
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!